#United States #Premier Inc. #Clearwater, Florida #Pharmacy Compounding #BayCare Health

BayCare Health System Recognized for Excellence in Pharmacy Compounding

On July 31, 2025, BayCare Health System, a prominent not-for-profit organization serving West Central Florida, was awarded the esteemed 2025 Pharmacy Compounding Excellence Award from Premier, Inc. This recognition highlights the organization’s commitment to providing safe and effective compounding services tailored to the needs of their patients and responding adeptly to industry challenges.

The award was presented at the Breakthroughs Conference & Exhibition, a significant event in healthcare that took place from July 15 to 17, 2025. Accepting the award were Mike Magee, BayCare's Vice President and Chief Pharmacy Officer, and Ken Jozefczyk, the Director of BayCare Central Pharmacy. Magee emphasized the importance of this achievement during the event, remarking, "What a great honor to accept the Premier Excellence in Compounding Award on behalf of BayCare Health System."

Commitment to Excellence

BayCare's recognition stems from their exceptional practices in compounding operations, demonstrating outstanding leadership and the ability to adapt to changes within the healthcare environment. The Pharmacy Compounding Excellence Award criteria include:

• - Leadership in Compounding Practice: Utilization of innovative technologies and effective workflow processes.
• - Comprehensive Services: Ensuring safety and efficiency for staff and patients while providing timely access to compounded products.
• - Continuous Education: Commitment to regular training, ensuring staff are equipped with current best practices.
• - Innovation: Creative strategies to enhance patient access to high-quality compounded medications.
• - Regulatory Compliance: Adherence to USP standards and active participation in relevant healthcare collaborations.

BayCare has a reputation for excellence in providing healthcare services, serving a large portion of the Tampa Bay community. Their facility is among four in the United States that are FDA-approved for 503B compounding, which allows for the preparation of sterile medications in bulk, addressing specific healthcare needs. Magee noted that this facility plays a crucial role in managing drug shortages and delivering effective treatments to their patients.

The Impact of the Award

The 2025 Pharmacy Compounding Excellence Award from Premier, Inc. is significant as it not only recognizes BayCare for their high standards but also showcases their efforts in setting benchmarks within the pharmacy compounding field. Premier, known as a leading technology-driven health care performance improvement company, supports its members by fostering quality improvement across healthcare systems.

BayCare's achievement signifies their dedication to operating at exceptional standards, thereby enhancing the quality of healthcare delivery in the region. This recognition motivates BayCare to continue innovating and improving patient care for the community it serves.

About BayCare Health System

BayCare Health System connects patients and families to an array of healthcare services, operating 16 hospitals, including a children's hospital, and many outpatient locations across central Florida. Its providers, such as BayCare Medical Group, are among the largest in the region, emphasizing behavioral health as well as pediatric services. Their mission is to promote health in the communities they serve through compassionate and quality healthcare services.

For further information regarding BayCare and their services, visit BayCare.org.